Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.72% | 46.20% | -43.36% | -24.17% | -21.69% |
| Total Depreciation and Amortization | 6.34% | 8.94% | 8.25% | 12.39% | 16.57% |
| Total Amortization of Deferred Charges | -42.89% | -35.96% | -23.64% | -11.29% | -1.13% |
| Total Other Non-Cash Items | -81.88% | -95.73% | 10.21% | 16.41% | 9.89% |
| Change in Net Operating Assets | 36.72% | 385.51% | -123.32% | -81.35% | -112.89% |
| Cash from Operations | -871.24% | -265.40% | -168.42% | -79.98% | -94.09% |
| Capital Expenditure | 55.66% | 58.42% | 52.87% | 53.86% | 54.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -17,189.91% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.26% | -80.14% | -85.73% | -27.46% | -58.48% |
| Cash from Investing | -29.15% | -5.99% | -3.62% | 23.97% | 80.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 97.68% | -3,785.83% | -3,808.48% | -3,861.99% | -3,960.86% |
| Issuance of Common Stock | 219.73% | -- | 378.53% | 122.89% | 122.89% |
| Repurchase of Common Stock | -219.73% | -158.44% | -162.20% | -167.88% | -116.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -738.44% | -250.16% | -148.53% | 93.44% | 97.61% |
| Cash from Financing | 93.00% | -26,591.24% | -26,355.59% | -465.61% | -285.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.22% | -23,006.56% | -4,229.25% | -315.48% | -341.73% |